Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib-Reference-Cited by-同舟云学术

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

Published:2018-11-26 Issue:5 Volume:185 Page:944-947
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mian Michael¹²^ORCID,Pescosta Norbert¹,Badiali Stefania³,Cappelletto Paola Cristina⁴,Marcheselli Luigi³,Luminari Stefano⁵,Patriarca Francesca⁶^ORCID,Zambello Renato⁷,Pascarella Anna⁸,Tagariello Giuseppe⁹,Marabese Alessandra¹,Mondello Patrizia¹⁰¹¹¹²^ORCID,Billio Atto¹,Cortelazzo Sergio¹³

Affiliation:

1. Department of Haematology & CBMT Hospital of Bolzano Bolzano Italy

2. Internal Medicine V Haematology & Oncology Medical University of Innsbruck Innsbruck Austria

3. Fondazione Italiana LInfomi Modena and AlessandriaItaly

4. Hospital Pharmacy Hospital of Bolzano Bolzano Italy

5. Haematology Santa Maria Nuova Hospital IRCCS Reggio Emilia Italy

6. ClinicaEmatologica e Unita' di TerapieCellulari “Carlo Melzi” Azienda Ospedaliera‐Universitaria UdineItaly

7. Padua University School of Medicine PadovaItaly

8. U.O. Ematologia Ospedaledell'Angelo Venezia‐MestreItaly

9. Transfusion Service Haemophilia Centre and Haematology Laboratory Analysis Castelfranco Veneto Hospital Castelfranco VenetoItaly

10. Department of Human Pathology University of MessinaMessina Italy

11. Department of Biological and Environmental Sciences University of Messina Messina Italy